abi-h0731
Showing 1 - 6 of 6
Chronic Hepatitis B Trial in China (ABI-H0731, ETV, Peg-IFNa)
Active, not recruiting
- Chronic Hepatitis B
- ABI-H0731
- +2 more
-
Beijing, Beijing, China
- +8 more
Mar 17, 2022
Chronic Hepatitis B Trial in Worldwide (ABI-H0731, SOC NrtI)
Terminated
- Chronic Hepatitis B
- ABI-H0731
- SOC NrtI
-
Beverly Hills, California
- +23 more
Mar 22, 2022
Chronic Hepatitis B Trial in Worldwide (ABI-H0731, SOC ETV, Placebo Oral Tablet)
Completed
- Chronic Hepatitis B
- ABI-H0731
- +2 more
-
Coronado, California
- +11 more
Jan 8, 2021
Chronic Hepatitis B Trial in Canada, New Zealand, United States (ABI-H0731, SOC NUC, Placebo Oral Tablet)
Completed
- Chronic Hepatitis B
- ABI-H0731
- +2 more
-
Beverly Hills, California
- +20 more
Jan 29, 2021
Chronic Hepatitis B Trial in Auckland, Hamilton (ABI-H0731, Placebo for ABI-H0731, Entecavir)
Completed
- Chronic Hepatitis B
- ABI-H0731
- +5 more
-
Auckland, New Zealand
- +1 more
Apr 2, 2019
Chronic Hepatitis B Trial in Worldwide (ABI-H0731, Placebo for ABI-H0731, Entecavir)
Completed
- Chronic Hepatitis B
- ABI-H0731
- +4 more
-
Clayton, Victoria, Australia
- +13 more
Jul 3, 2018